Adlai Nortye ANL
NASDAQ ANL
$15.88 -0.12 (-0.77%)
As of: Oct 1, 2026 · 10:05 AM EDT

Adlai Nortye (ANL) Accounts Payables (2022 - 2026)

Updated

Adlai Nortye's Accounts Payables came in at $4.61 million for Q2 2026, down 52.4% from $9.68 million a year earlier.

Analysis

Adlai Nortye (ANL) Accounts Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye's Accounts Payables was $12.64 million, up 24.6% from FY2024.

  • Accounts Payables carries a three-year compound annual growth rate of -1.2% (FY2022 to FY2025).
  • Going back by year, Accounts Payables was $10.15 million in FY2024 (-29.3%), $14.35 million in FY2023 (+9.5%) and $13.1 million in FY2022.
  • Year-over-year, Accounts Payables increased in 1 of the last four quarters, with an average decline of 17.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Adlai Nortye 549.39 Mn 450.09 Mn - 4.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.61 Mn
Dec 31, 2025 12.64 Mn
Jun 30, 2025 9.68 Mn
Dec 31, 2024 10.15 Mn
Jun 30, 2024 11.00 Mn
Dec 31, 2023 14.35 Mn
Dec 31, 2022 13.10 Mn
API Access

Adlai Nortye Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANL&period=max&api_key=YOUR_API_KEY